You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 23, 2024

PYLERA Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for PYLERA?
  • What are the global sales for PYLERA?
  • What is Average Wholesale Price for PYLERA?
Summary for PYLERA
Drug patent expirations by year for PYLERA
Drug Prices for PYLERA

See drug prices for PYLERA

Recent Clinical Trials for PYLERA

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of CoimbraN/A
Centro Hospitalar e Universitário de Coimbra, E.P.E.N/A
Hospital da Senhora da OliveiraEarly Phase 1

See all PYLERA clinical trials

Paragraph IV (Patent) Challenges for PYLERA
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
PYLERA Capsules bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride 140 mg/125 mg/ 125 mg 050786 1 2014-08-12

US Patents and Regulatory Information for PYLERA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for PYLERA

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006 ⤷  Sign Up ⤷  Sign Up
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006 ⤷  Sign Up ⤷  Sign Up
Labs Juvise PYLERA bismuth subcitrate potassium; metronidazole; tetracycline hydrochloride CAPSULE;ORAL 050786-001 Sep 28, 2006 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

International Patents for PYLERA

See the table below for patents covering PYLERA around the world.

Country Patent Number Title Estimated Expiration
Turkey 200001761 ⤷  Sign Up
Poland 192541 ⤷  Sign Up
European Patent Office 1037614 DOUBLE CAPSULE POUR ADMINISTRER DES PRINCIPES ACTIFS SELON UNE POLYTHERAPIE (A DOUBLE CAPSULE FOR THE ADMINISTRATION OF ACTIVE PRINCIPLES IN MULTIPLE THERAPIES) ⤷  Sign Up
Portugal 1037614 ⤷  Sign Up
Canada 1330759 METHODE DE TRAITEMENT D'AFFECTIONS GASTRO-INTESTINALES (METHOD FOR THE TREATMENT OF GASTRO INTESTINAL DISORDERS) ⤷  Sign Up
Japan 2002508312 ⤷  Sign Up
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.